Literature DB >> 30860628

Beta-lactam-induced severe neutropenia: a descriptive study.

Richard H Aster1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30860628      PMCID: PMC6508587          DOI: 10.1111/fcp.12449

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


× No keyword cloud information.
  15 in total

1.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.

Authors:  Patricia T Illing; Julian P Vivian; Nadine L Dudek; Lyudmila Kostenko; Zhenjun Chen; Mandvi Bharadwaj; John J Miles; Lars Kjer-Nielsen; Stephanie Gras; Nicholas A Williamson; Scott R Burrows; Anthony W Purcell; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

Review 2.  Drug-induced immune thrombocytopenia.

Authors:  Richard H Aster; Daniel W Bougie
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

Review 3.  Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.

Authors:  Alexander Johnston; Jack Uetrecht
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-11-26       Impact factor: 4.481

Review 4.  Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007.

Authors:  George Garratty; Patricia A Arndt
Journal:  Immunohematology       Date:  2014

Review 5.  The structural basis of HLA-associated drug hypersensitivity syndromes.

Authors:  Yuri A Pompeu; Jon D Stewart; Simon Mallal; Elizabeth Phillips; Bjoern Peters; David A Ostrov
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 6.  Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.

Authors:  R H Aster; B R Curtis; J G McFarland; D W Bougie
Journal:  J Thromb Haemost       Date:  2009-04-02       Impact factor: 5.824

Review 7.  A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia.

Authors:  D M Arnold; S Kukaswadia; I Nazi; A Esmail; L Dewar; J W Smith; T E Warkentin; J G Kelton
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

8.  Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.

Authors:  James Yun; Maria J Marcaida; Klara K Eriksson; Heidi Jamin; Stefano Fontana; Werner J Pichler; Daniel Yerly
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

Review 9.  Antimicrobial drug-induced thrombocytopenia: a review of the literature.

Authors:  Angela S Loo; Lana Gerzenshtein; Michael G Ison
Journal:  Semin Thromb Hemost       Date:  2012-10-18       Impact factor: 4.180

10.  Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G.

Authors:  B B LEVINE; Z OVARY
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.